160 related articles for article (PubMed ID: 22805008)
21. Expression of hypoxia-inducible factor 1α predicts clinical outcome after preoperative hyperthermo-chemoradiotherapy for locally advanced rectal cancer.
Shioya M; Takahashi T; Ishikawa H; Sakurai H; Ebara T; Suzuki Y; Saitoh J; Ohno T; Asao T; Kuwano H; Nakano T
J Radiat Res; 2011; 52(6):821-7. PubMed ID: 22104271
[TBL] [Abstract][Full Text] [Related]
22. Enrichment of CD133-expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survival.
Sprenger T; Conradi LC; Beissbarth T; Ermert H; Homayounfar K; Middel P; Rüschoff J; Wolff HA; Schüler P; Ghadimi BM; Rödel C; Becker H; Rödel F; Liersch T
Cancer; 2013 Jan; 119(1):26-35. PubMed ID: 22736392
[TBL] [Abstract][Full Text] [Related]
23. Tafazzin protein expression is associated with tumorigenesis and radiation response in rectal cancer: a study of Swedish clinical trial on preoperative radiotherapy.
Pathak S; Meng WJ; Zhang H; Gnosa S; Nandy SK; Adell G; Holmlund B; Sun XF
PLoS One; 2014; 9(5):e98317. PubMed ID: 24858921
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of fibroblast growth factor receptor 2 expression in patients with residual rectal cancer after preoperative chemoradiotherapy: relationship with KRAS or BRAF mutations and MSI status.
Yoon G; Lee H; Kim JH; Hur K; Seo AN
Tumour Biol; 2016 Aug; 37(8):10209-18. PubMed ID: 26831663
[TBL] [Abstract][Full Text] [Related]
25. Phosphatidylinositol 3-kinase CB association with preoperative radiotherapy response in rectal adenocarcinoma.
Yu WD; Peng YF; Pan HD; Wang L; Li K; Gu J
World J Gastroenterol; 2014 Nov; 20(43):16258-67. PubMed ID: 25473181
[TBL] [Abstract][Full Text] [Related]
26. Podocalyxin-like protein expression in primary colorectal cancer and synchronous lymph node metastases.
Larsson AH; Nodin B; Syk I; Palmquist I; Uhlén M; Eberhard J; Jirström K
Diagn Pathol; 2013 Jul; 8():109. PubMed ID: 23819542
[TBL] [Abstract][Full Text] [Related]
27. Lymph node count after preoperative radiotherapy is an independently prognostic factor for pathologically lymph node-negative patients with rectal cancer.
Li Q; Zhuo C; Liang L; Zheng H; Li D; Cai S
Medicine (Baltimore); 2015 Jan; 94(3):e395. PubMed ID: 25621683
[TBL] [Abstract][Full Text] [Related]
28. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of Smac expression in rectal cancer patients treated with neoadjuvant therapy.
Yan H; Yu J; Wang R; Jiang S; Zhu K; Mu D; Xu Z
Med Oncol; 2012 Mar; 29(1):168-73. PubMed ID: 21264534
[TBL] [Abstract][Full Text] [Related]
30. PD-L1 is upregulated by radiochemotherapy in rectal adenocarcinoma patients and associated with a favourable prognosis.
Hecht M; Büttner-Herold M; Erlenbach-Wünsch K; Haderlein M; Croner R; Grützmann R; Hartmann A; Fietkau R; Distel LV
Eur J Cancer; 2016 Sep; 65():52-60. PubMed ID: 27468145
[TBL] [Abstract][Full Text] [Related]
31. hPEBP4 as a predictive marker for the pathological response of rectal cancer to preoperative radiotherapy.
Qiu J; Yang G; Shen Z; Xie Y; Wang L
Int J Colorectal Dis; 2013 Feb; 28(2):241-6. PubMed ID: 22801881
[TBL] [Abstract][Full Text] [Related]
32. Expression of MAC30 in rectal cancers with or without preoperative radiotherapy.
Zhang ZY; Zhao ZR; Adell G; Jarlsfelt I; Cui YX; Kayed H; Kleeff J; Wang MW; Sun XF
Oncology; 2006; 71(3-4):259-65. PubMed ID: 17657172
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of response to preoperative radiotherapy, lymph node metastasis, and CEA level in patients undergoing total mesorectal excision of rectal cancer.
Ishihara S; Watanabe T; Kiyomatsu T; Yasuda K; Nagawa H
Int J Colorectal Dis; 2010 Dec; 25(12):1417-25. PubMed ID: 20809426
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy.
Giralt J; Navalpotro B; Hermosilla E; de Torres I; Espin E; Reyes V; Cerezo L; de las Heras M; Ramon y Cajal S; Armengol M; Benavente S
Oncology; 2006; 71(5-6):312-9. PubMed ID: 17687192
[TBL] [Abstract][Full Text] [Related]
35. Expression of PRL proteins at invasive margin of rectal cancers in relation to preoperative radiotherapy.
Wallin AR; Svanvik J; Adell G; Sun XF
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):452-8. PubMed ID: 16626893
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
[TBL] [Abstract][Full Text] [Related]
37. Combination of growth pattern and tumor regression identifies a high-risk group in neoadjuvant treated rectal cancer patients.
Jessberger J; Erlenbach-Wünsch K; Posselt R; Haderlein M; Agaimy A; Fietkau R; Hartmann A; Distel L
J Dig Dis; 2017 May; 18(5):283-291. PubMed ID: 28342240
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Impact of Lymph Node Ratio in Patients Undergoing Preoperative Chemoradiotherapy Followed by Curative Resection for Locally Advanced Rectal Cancer.
Jung W; Kim K; Kim J; Shim SJ
In Vivo; 2020; 34(3):1247-1253. PubMed ID: 32354915
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors for survival in stage IV rectal cancer: A Swedish nationwide case-control study.
Afshari K; Chabok A; Naredi P; Smedh K; Nikberg M
Surg Oncol; 2019 Jun; 29():102-106. PubMed ID: 31196471
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
Akiyoshi T; Toda S; Tominaga T; Oba K; Tomizawa K; Hanaoka Y; Nagasaki T; Konishi T; Matoba S; Fukunaga Y; Ueno M; Kuroyanagi H
BJS Open; 2019 Dec; 3(6):822-829. PubMed ID: 31832589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
